Anita Rachmawati
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Research Interests
Anita Rachmawati has a total of 15 co-authors. Here are the top co-authors by number of shared publications:
- Dian Tjahyadi
Division of Reproductive Endocrinology and Infertility, Department of Obstetrics and Gynecology, Hasan Sadikin General Teaching Hospital, Faculty of Medicine, Padjadjaran University, Bandung, West Java, Indonesia
2 shared publications - Ruswana Anwar
Department of Obstetrics and Gynecology, Hasan Sadikin General Teaching Hospital, Faculty of Medicine, Padjadjaran University, Bandung, West Java, Indonesia
2 shared publications - Wiryawan Permadi
Division of Reproductive Endocrinology and Infertility, Department of Obstetrics and Gynecology, Hasan Sadikin General Teaching Hospital, Faculty of Medicine, Padjadjaran University, Bandung, West Java, Indonesia
2 shared publications - Anom Suardika
Division of Reproductive Endocrinology and Infertility, Department of Obstetrics and Gynecology, Prof. Dr. I.G.N.G. Ngoerah General Hospital / Faculty of Medicine, Udayana University, Denpasar, Bali, Indonesia
1 shared publication - Artha Falentin Putri Susilo
Fertility and Reproductive Endocrinology Division, Faculty of Medicine, Padjadjaran University – Dr. Hasan Sadikin General Hospital, Bandung, Indonesia
1 shared publication - Dewi Rani Pelitawati
Faculty of Medicine, Padjadjaran University, Bandung, West Java, Indonesia
1 shared publication
Latest Publications
- Open Access
- 1 July 2026
- Published by Taylor & Francis in International Journal of Women's Health
- Vol. ume 18, 1-14
The Association of Methylenetetrahydrofolate Reductase C677T Polymorphism, Serum 5-Methyltetrahydrofolate, and Homocysteine Levels with Adenomyosis: A Cross-Sectional Study in an Indonesian Population
Purpose: Adenomyosis is a complex uterine condition, with emerging evidence indicating epigenetic alterations play a role in its pathogenesis. The methylenetetrahydrofolate reductase (MTHFR) gene polymorphism C677T may reduce enzyme activity, affecting DNA methylation and increasing adenomyosis risk. This study compares the MTHFR C677T polymorphism, 5-methyltetrahydrofolate (5-MTHF) levels, and homocysteine levels in patients with adenomyosis. Patients and Methods: This cross-sectional study involved 61 subjects: 31 patients with adenomyosis and 30 patients as controls. The MTHFR C677T polymorphism was analyzed using PCR-RFLP, serum 5-MTHF and homocysteine levels were measured using ELISA. Statistical analyses were performed to compare genotype distributions and metabolite levels between groups and within the adenomyosis group based on genotype. Results: The study found a significant difference in the distribution of the MTHFR C677T genotype between adenomyosis and control groups (p=0.018), with a higher prevalence of the CT genotype in the adenomyosis group (35.5% vs 10.0%). The frequency of the T allele was also elevated in the adenomyosis group (17.7% vs 5.0%; p=0.027). Serum 5-MTHF levels were notably lower in the adenomyosis group (23.92 ± 4.599 nmol/l) compared to controls (32.45 ± 3.019 nmol/l; p< 0.0001), while homocysteine levels were significantly higher in the adenomyosis group (12.87 ± 8.916 µmol/L vs 8.61 ± 1.352 µmol/L; p=0.019). Further analysis of MTHFR genotypes indicated lower 5-MTHF levels in both CC and CT genotypes among the adenomyosis group compared to controls (p< 0.0001). Homocysteine levels showed no significant difference across genotypes (p=0.074), though there was a trend towards higher levels in the adenomyosis group. Conclusion: This study demonstrates a significant difference in the distribution of the MTHFR C677T polymorphism, lower 5-MTHF levels, and higher homocysteine levels in patients with adenomyosis compared to controls. Lower 5-MTHF levels were also shown to be strongly linked with the heterozygous C677T polymorphism in the adenomyosis group.
- 1 July 2026
- Published by Taylor & Francis in International Journal of Women's Health
- Vol. ume 18, 1-14
Open AccessThe Association of Methylenetetrahydrofolate Reductase C677T Polymorphism, Serum 5-Methyltetrahydrofolate, and Homocysteine Levels with Adenomyosis: A Cross-Sectional Study in an Indonesian Population
Purpose: Adenomyosis is a complex uterine condition, with emerging evidence indicating epigenetic alterations play a role in its pathogenesis. The methylenetetrahydrofolate reductase (MTHFR) gene polymorphism C677T may reduce enzyme activity, affecting DNA methylation and increasing adenomyosis risk. This study compares the MTHFR C677T polymorphism, 5-methyltetrahydrofolate (5-MTHF) levels, and homocysteine levels in patients with adenomyosis. Patients and Methods: This cross-sectional study involved 61 subjects: 31 patients with adenomyosis and 30 patients as controls. The MTHFR C677T polymorphism was analyzed using PCR-RFLP, serum 5-MTHF and homocysteine levels were measured using ELISA. Statistical analyses were performed to compare genotype distributions and metabolite levels between groups and within the adenomyosis group based on genotype. Results: The study found a significant difference in the distribution of the MTHFR C677T genotype between adenomyosis and control groups (p=0.018), with a higher prevalence of the CT genotype in the adenomyosis group (35.5% vs 10.0%). The frequency of the T allele was also elevated in the adenomyosis group (17.7% vs 5.0%; p=0.027). Serum 5-MTHF levels were notably lower in the adenomyosis group (23.92 ± 4.599 nmol/l) compared to controls (32.45 ± 3.019 nmol/l; p< 0.0001), while homocysteine levels were significantly higher in the adenomyosis group (12.87 ± 8.916 µmol/L vs 8.61 ± 1.352 µmol/L; p=0.019). Further analysis of MTHFR genotypes indicated lower 5-MTHF levels in both CC and CT genotypes among the adenomyosis group compared to controls (p< 0.0001). Homocysteine levels showed no significant difference across genotypes (p=0.074), though there was a trend towards higher levels in the adenomyosis group. Conclusion: This study demonstrates a significant difference in the distribution of the MTHFR C677T polymorphism, lower 5-MTHF levels, and higher homocysteine levels in patients with adenomyosis compared to controls. Lower 5-MTHF levels were also shown to be strongly linked with the heterozygous C677T polymorphism in the adenomyosis group.
- 22 June 2026
- Published by IRBIS in Obstetrics, Gynecology and Reproduction
Association between sperm morphology and embryo cleavage rate in in vitro fertilization: a retrospective study
Introduction . Infertility is a major reproductive health problem, and in vitro fertilization (IVF) with intracytoplasmic sperm injection (ICSI) is widely used to improve conception in infertile couples. Embryo cleavage rate is an important laboratory indicator of early embryo development, while sperm morphology may reflect sperm structural and genetic integrity. Aim : to analyze the association between sperm morphology and embryo cleavage rate in patients undergoing IVF/ICSI. Materials and Methods . This analytical retrospective study used medical records of infertile couples undergoing IVF/ICSI at Dr. Hasan Sadikin Central General Hospital (Bandung) from January 2020 to December 2024. Patients with complete semen analysis based on World Health Organization (WHO) 2021 criteria and embryo development data up to day 2 post-fertilization were included. Sperm morphology was classified as normospermia or teratozoospermia, and cleavage rate as rapid, normal, or slow. Statistical analysis was performed using the Chi-square test, with odds ratios (ORs) and 95 % confidence intervals (CIs). Results . A total of 159 records were analyzed. Sperm morphology was significantly associated with cleavage rate (p = 0.001). Teratozoospermia was found in 97.0 % of rapid cleavage cases, 47.3 % of normal cleavage cases, and 93.9 % of slow cleavage cases. Teratozoospermia was associated with higher odds of rapid cleavage (OR = 35.636; 95 % CI = 4.673–271.760) and slow cleavage (OR = 17.261; 95 % CI = 3.903–76.340). Conclusion . Sperm morphology is significantly associated with embryo cleavage rate in IVF/ICSI. Teratozoospermia may be related to altered timing of early embryo cleavage and may serve as an additional prognostic parameter in IVF/ICSI counseling and laboratory assessment.
- 22 June 2026
- Published by IRBIS in Obstetrics, Gynecology and Reproduction
Association between sperm morphology and embryo cleavage rate in in vitro fertilization: a retrospective study
Introduction . Infertility is a major reproductive health problem, and in vitro fertilization (IVF) with intracytoplasmic sperm injection (ICSI) is widely used to improve conception in infertile couples. Embryo cleavage rate is an important laboratory indicator of early embryo development, while sperm morphology may reflect sperm structural and genetic integrity. Aim : to analyze the association between sperm morphology and embryo cleavage rate in patients undergoing IVF/ICSI. Materials and Methods . This analytical retrospective study used medical records of infertile couples undergoing IVF/ICSI at Dr. Hasan Sadikin Central General Hospital (Bandung) from January 2020 to December 2024. Patients with complete semen analysis based on World Health Organization (WHO) 2021 criteria and embryo development data up to day 2 post-fertilization were included. Sperm morphology was classified as normospermia or teratozoospermia, and cleavage rate as rapid, normal, or slow. Statistical analysis was performed using the Chi-square test, with odds ratios (ORs) and 95 % confidence intervals (CIs). Results . A total of 159 records were analyzed. Sperm morphology was significantly associated with cleavage rate (p = 0.001). Teratozoospermia was found in 97.0 % of rapid cleavage cases, 47.3 % of normal cleavage cases, and 93.9 % of slow cleavage cases. Teratozoospermia was associated with higher odds of rapid cleavage (OR = 35.636; 95 % CI = 4.673–271.760) and slow cleavage (OR = 17.261; 95 % CI = 3.903–76.340). Conclusion . Sperm morphology is significantly associated with embryo cleavage rate in IVF/ICSI. Teratozoospermia may be related to altered timing of early embryo cleavage and may serve as an additional prognostic parameter in IVF/ICSI counseling and laboratory assessment.
- Open Access
- 1 May 2026
- Published by Taylor & Francis in International Journal of Women's Health
- Vol. ume 18, 1-14
The Impact of Endometriosis on Ovarian Reserve: A Systematic Review
Endometriosis is a chronic inflammatory condition, causing severe pelvic pain, organ dysfunction, infertility, and mental health issues. Ovarian reserve, indicating the quantity and quality of a woman’s oocytes, is negatively affected by endometriosis, especially in cases with ovarian endometriomas. This comprehensive narrative review aims to synthesize and critically evaluate the current evidence on the impact of endometriosis on ovarian reserve. A systematic literature search was conducted across several databases, including PubMed, Semantic Scholar, ProQuest, Scopus, and Springer. The inclusion criteria encompassed studies published in English between 2015 and 2024. The review process was conducted in accordance with Preferred Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA) guideline. Studies were critically appraised for quality using Newcastle-Ottawa Scale (NOS) for observational studies and the Cochrane Risk of Bias Tool (RoB 2.0) for randomized trials. A total of 10 studies were included in this systematic review. The evidence shows that endometriosis significantly reduces ovarian reserve in women, as indicated by lower Anti-Müllerian Hormone (AMH) levels and Antral Follicle Count (AFC) compared to healthy individuals. The condition is linked to chronic pelvic inflammation due to local pro-inflammatory cytokines disrupting ovarian function and oxidative stress from reactive oxygen species damaging oocytes. While surgical interventions like cystectomy help manage symptoms and may enhance fertility, they also risk further reducing ovarian reserve by removing healthy ovarian tissue. This review underscores the importance of early diagnosis and personalized management strategies to preserve ovarian function and fertility. Future research should focus on developing effective treatment strategies that consider immune and hormonal influences, exploring new methods to protect and regenerate ovarian reserve in affected women, and analyzing subtypes along with the impact of clinical versus surgical diagnosis of endometriosis.
- 1 May 2026
- Published by Taylor & Francis in International Journal of Women's Health
- Vol. ume 18, 1-14
Open AccessThe Impact of Endometriosis on Ovarian Reserve: A Systematic Review
Endometriosis is a chronic inflammatory condition, causing severe pelvic pain, organ dysfunction, infertility, and mental health issues. Ovarian reserve, indicating the quantity and quality of a woman’s oocytes, is negatively affected by endometriosis, especially in cases with ovarian endometriomas. This comprehensive narrative review aims to synthesize and critically evaluate the current evidence on the impact of endometriosis on ovarian reserve. A systematic literature search was conducted across several databases, including PubMed, Semantic Scholar, ProQuest, Scopus, and Springer. The inclusion criteria encompassed studies published in English between 2015 and 2024. The review process was conducted in accordance with Preferred Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA) guideline. Studies were critically appraised for quality using Newcastle-Ottawa Scale (NOS) for observational studies and the Cochrane Risk of Bias Tool (RoB 2.0) for randomized trials. A total of 10 studies were included in this systematic review. The evidence shows that endometriosis significantly reduces ovarian reserve in women, as indicated by lower Anti-Müllerian Hormone (AMH) levels and Antral Follicle Count (AFC) compared to healthy individuals. The condition is linked to chronic pelvic inflammation due to local pro-inflammatory cytokines disrupting ovarian function and oxidative stress from reactive oxygen species damaging oocytes. While surgical interventions like cystectomy help manage symptoms and may enhance fertility, they also risk further reducing ovarian reserve by removing healthy ovarian tissue. This review underscores the importance of early diagnosis and personalized management strategies to preserve ovarian function and fertility. Future research should focus on developing effective treatment strategies that consider immune and hormonal influences, exploring new methods to protect and regenerate ovarian reserve in affected women, and analyzing subtypes along with the impact of clinical versus surgical diagnosis of endometriosis.
- Open Access
- 23 March 2026
- Published by International Scientific Information, Inc. in American Journal of Case Reports
- Vol. 27, e947844
Isolated Premature Menarche in a 17-Month-Old: A Case Report
BACKGROUND Vaginal bleeding in prepubertal girls is an uncommon finding and should always prompt thorough evaluation. Puberty is a complex physiological process resulting from maturation of the hypothalamic-pituitary-gonadal axis. Precocious puberty is defined as the early onset of secondary sexual characteristics before the age of 8 years in girls. The incidence ranges from 1 in 5000 to 1 in 10 000 girls worldwide. In contrast, isolated premature menarche is a rare and benign condition characterized by vaginal bleeding without other signs of pubertal activation and remains a diagnosis of exclusion. CASE REPORT We report a 17-month-old female infant who presented with recurrent vaginal bleeding every month over the 3 months prior to admission. Physical examination showed normal external genitalia, with no signs of inflammation, trauma, foreign body, or sexual abuse. There were no secondary sexual characteristics, and growth parameters were appropriate for age. Laboratory examination revealed prepubertal basal gonadotropin levels, normal hormonal levels, normal thyroid function tests, and bone age consistent with chronological age. Platelet function testing showed hyperaggregation, considered a transient and incidental finding. Pelvic ultrasonography demonstrated the size of the uterus was consistent with the age of puberty. After exclusion of local, endocrine, and systemic causes, a diagnosis of isolated premature menarche was established. CONCLUSIONS Menstrual-like vaginal bleeding in prepubertal girls requires systematic and comprehensive examination to differentiate isolated premature menarche from other diseases. Recognition of this benign entity is important to avoid unnecessary interventions and ascertain appropriate follow-up.
- 23 March 2026
- Published by International Scientific Information, Inc. in American Journal of Case Reports
- Vol. 27, e947844
Open AccessIsolated Premature Menarche in a 17-Month-Old: A Case Report
BACKGROUND Vaginal bleeding in prepubertal girls is an uncommon finding and should always prompt thorough evaluation. Puberty is a complex physiological process resulting from maturation of the hypothalamic-pituitary-gonadal axis. Precocious puberty is defined as the early onset of secondary sexual characteristics before the age of 8 years in girls. The incidence ranges from 1 in 5000 to 1 in 10 000 girls worldwide. In contrast, isolated premature menarche is a rare and benign condition characterized by vaginal bleeding without other signs of pubertal activation and remains a diagnosis of exclusion. CASE REPORT We report a 17-month-old female infant who presented with recurrent vaginal bleeding every month over the 3 months prior to admission. Physical examination showed normal external genitalia, with no signs of inflammation, trauma, foreign body, or sexual abuse. There were no secondary sexual characteristics, and growth parameters were appropriate for age. Laboratory examination revealed prepubertal basal gonadotropin levels, normal hormonal levels, normal thyroid function tests, and bone age consistent with chronological age. Platelet function testing showed hyperaggregation, considered a transient and incidental finding. Pelvic ultrasonography demonstrated the size of the uterus was consistent with the age of puberty. After exclusion of local, endocrine, and systemic causes, a diagnosis of isolated premature menarche was established. CONCLUSIONS Menstrual-like vaginal bleeding in prepubertal girls requires systematic and comprehensive examination to differentiate isolated premature menarche from other diseases. Recognition of this benign entity is important to avoid unnecessary interventions and ascertain appropriate follow-up.